Cytek Biosciences, Inc. (CTKB)
Healthcare • Medical Devices
StockNasdaqGSUnited StatesUS23285D1090
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Cytek Biosciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:54. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | 0.03 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.07 | -0.05 | +28.6% | Beat |
| 05 Aug 2026 16:00 | -0.02 | -0.03 | -55.0% | Miss |
| 07 May 2026 16:00 | -0.08 | -0.10 | -20.0% | Miss |
| 26 Feb 2026 16:00 | 0.02 | -0.29 | -2,014.7% | Miss |
| 05 Nov 2025 16:00 | 0.01 | — | -103.0% | — |
| 06 Aug 2025 16:00 | -0.01 | -0.01 | +52.5% | Beat |
| 08 May 2025 16:00 | 0.01 | -0.03 | -372.0% | Miss |
| 27 Feb 2025 16:00 | 0.10 | 0.12 | +11.7% | Beat |
| 05 Nov 2024 16:00 | 0.04 | 0.06 | +52.2% | Beat |
| 06 Aug 2024 16:00 | 0.01 | -0.01 | -157.0% | Miss |
| 08 May 2024 16:00 | — | -0.01 | — | — |
| 13 Mar 2024 16:00 | 0.04 | 0.08 | +97.5% | Beat |
| 07 Nov 2023 16:00 | 0.02 | -0.01 | -125.5% | Miss |
| 08 Aug 2023 16:00 | 0.02 | — | -91.3% | — |
| 09 May 2023 16:00 | 0.03 | — | -100.0% | — |
| 28 Feb 2023 16:00 | 0.07 | 0.07 | +1.8% | Beat |
| 09 Nov 2022 16:00 | 0.03 | 0.04 | +33.3% | Beat |
| 10 Aug 2022 16:00 | 0.04 | 0.03 | -25.0% | Miss |
| 11 May 2022 16:00 | 0.02 | -0.02 | -200.0% | Miss |
| 23 Feb 2022 16:00 | 0.03 | 0.03 | +20.0% | Beat |
| 08 Nov 2021 16:00 | 0.02 | 0.01 | -40.0% | Miss |
| 02 Sep 2021 16:00 | — | — | — | — |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 201.5M | +0.5% | -66.5M | -33.0% | -0.52 | -940.0% | -8.9M |
| 2024 | 200.5M | +3.9% | -6M | -3.0% | -0.05 | +42.3% | 21.7M |
| 2023 | 193M | +17.7% | -12.1M | -6.3% | -0.09 | -533.4% | 454K |
| 2022 | 164M | — | 2.6M | 1.6% | 0.02 | — | -22.1M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 6.19 | 6.19 | 5.31 | 5.51 | -10.20% | 11,924,975 | |
| Oct 2026 | 5.96 | 6.34 | 5.05 | 6.13 | +2.85% | 31,204,100 | |
| Sep 2026 | 4.78 | 5.99 | 4.49 | 5.96 | +24.69% | 27,755,800 | |
| Aug 2026 | 4.31 | 4.94 | 4.05 | 4.78 | +13.27% | 18,192,000 | |
| Jul 2026 | 4.45 | 4.80 | 4.14 | 4.22 | -4.74% | 17,316,300 | |
| Jun 2026 | 4.20 | 4.63 | 3.70 | 4.43 | +5.73% | 48,396,700 | |
| May 2026 | 4.59 | 4.99 | 3.31 | 4.19 | -8.11% | 20,924,700 | |
| Apr 2026 | 4.43 | 4.85 | 4.10 | 4.56 | +4.35% | 11,666,700 | |
| Mar 2026 | 4.44 | 4.75 | 3.95 | 4.37 | -2.46% | 17,835,800 | |
| Feb 2026 | 5.00 | 5.29 | 4.09 | 4.48 | -10.40% | 16,599,700 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Stephens & Co. Maintains Overweight on Cytek Biosciences, Raises Price Target to $7 (opens in a new tab) Benzinga · 10 Nov 2026 10:09
- Cytek Biosciences, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 09 Nov 2026 18:42
- Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year (opens in a new tab) 05 Nov 2026 22:00
- Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 18:29
- Cytek Biosciences, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 13:30
- Cytek Biosciences, Inc. (CTKB) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 09:54
- Cytek Biosciences Inc (CTKB) Q3 2026 Earnings Call Highlights: U.S. ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 05:16
- Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
- Cytek Biosciences Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 04 Nov 2026 23:14
- Cytek Biosciences Reports Third Quarter 2026 Financial Results (opens in a new tab) 04 Nov 2026 21:05
- Cytek Biosciences Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 04 Nov 2026 18:21
- Cytek Biosciences Q3 EPS $(0.05) Beats $(0.08) Estimate, Sales $53.229M Beat $52.800M Estimate (opens in a new tab) Benzinga · 04 Nov 2026 17:27
- Cytek Biosciences Narrows FY2026 Sales Guidance from $207.000M-$212.000M to $208.000M-$211.000M vs $209.415M Est (opens in a new tab) Benzinga · 04 Nov 2026 17:14
- Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for (opens in a new tab) Zacks · 28 Oct 2026 13:00
- Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh Profitability (opens in a new tab) Simply Wall St. · 25 Oct 2026 01:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 5.76 USD
- Market cap
- 734.4M
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow CTKB and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.